The Effects of Hyperbaric Oxygen Treatment on... (2024 study) Skip to main content
Retrospective Study Cureus 2024

The Effects of Hyperbaric Oxygen Treatment on Verbal Scores in Children With Autism Spectrum Disorder: A Retrospective Trial.

Peterson T, Sherwin R, Hosey T, Close N, Strale F, Cureus, 2024

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers looked back at records of 65 children with autism spectrum disorder to see whether getting hyperbaric oxygen therapy along with behavior therapy was linked to different changes in verbal test scores.

What They Found

In this retrospective, non-randomised study of 65 children with autism spectrum disorder, those who received hyperbaric oxygen therapy plus applied behavior analysis (ABA) had larger gains on one verbal test, the VBMAPP, than children who received ABA alone, but not on a second test, the ABLLS. Children took their test twice, six months apart, and the HBOT group had at least 40 sessions of 100% oxygen at 2.0 ATA for 60 minutes. Among children given the VBMAPP (23 with HBOT, 12 with ABA alone), the total score rose by 46.41 in the HBOT group and 14.42 in the ABA-only group, with p less than 0.0001. Among the 30 children given the ABLLS, the total score rose by 268.89 with HBOT and 190.81 with ABA alone. That difference was not statistically significant (p greater than 0.2024), which the authors link to high variability between children.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study looked back at existing records without random assignment, the groups were small (only 12 children in the VBMAPP comparison group), and the ABLLS results varied so much between children that the study had low statistical power.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Neurological
Source Pubmed
PubMed ID 38318543
Year Published 2024
Journal Cureus

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology